Professor of Pediatrics
Division Head of the
Division of Rheumatology at
Childrens Hospital Los Angeles
Andreas Otto Reiff, MD, is a Professor of Pediatrics at Childrens Hospital Los Angeles, Keck School of Medicine and Division Head of the Division of Rheumatology at Childrens Hospital Los Angeles. He is also the director of the Pediatric Rheumatology Program at Miller Children’s Hospital in Long Beach, California and a Visiting Clinical Associate Professor, Department of Pediatrics, University of Nevada School of Medicine.
Dr. Reiff received his medical degree from University Medical School in Freiburg, Germany. Following an internship in internal medicine and surgery at Kantonsspital Liestal in Switzerland, he returned to Freiburg and completed his residency at the University Children’s Hospital.
He completed a research fellowship in the Division of Rheumatology and Bone Marrow Transplantation at Childrens Hospital Los Angeles between 1993 and 1994, and a fellowship in pediatric rheumatology at University Children’s Hospital in Freiburg from 1994 -1996.
An avid researcher and investigator, Dr. Reiff’s primary research interests include the treatment, management, and genetics of pediatric autoimmune diseases; treatment of inflammatory and degenerative eye diseases, and alternatives to stem cell transplantation. In addition to authoring and co-authoring numerous journal articles, abstracts, reviews, and book chapters, he has lectured on rheumatologic topics nationally and internationally. He is a clinical consultant for several pharmaceutical companies and serves on advisory boards for the Arthritis Foundation, Lupus LA, and on several CHLA committees. He is a well known national and international speaker on biologic drug development and the treatment of chronic inflammatory eye diseases.
Dr. Reiff is board-certified in pediatrics and pediatric rheumatology by the European Union and the American Board of Pediatrics. He is a member of the Southern California Rheumatology Society, the Pediatric Rheumatology Collaborative Study Group, and the American College of Rheumatology. In addition, he is a founding member of the pediatric rheumatology research network (CARRA). He has received several honors, grants, and awards.